ARTIFICIAL INTELLIGENCE
IN SUPPORT OF NEUROLOGY

Our mission is to offer a platform for "bench-to-bedside" innovations in neurology, and bring AI into the clinical workflow.

Time Savings Worth

850 Million €

...are possible by automating the process
of visual inspection and hand-written reporting.

Reduction of misdiagnoses rate by

50%

1 in 3 epilepsy diagnoses
turn out to have an alternate cause.

EEG CHALLENGES

Today, the standard of EEG analysis is by visual inspection. This process is time-consuming and error-prone. Moreover, obtaining a confident diagnosis is very much linked to the level of experience of the reviewing neurologist. Many people responsible for reading an EEG do not have formal training for doing so. Learning to read an EEG is not mandatory to become a neurologist.

OUR PLATFORM...

enables EEG diagnostics, powered by machine learning and artificial intelligence, and designed for the clinical workflow.

Available as a fully certified medical device by May 2021.

Free of charge to all Swiss university hospitals and research collaborators.

ACCURATE

Faster analyses and higher accuracies are realized by our deep learning solution, either on-par or outperforming human experts at classifying and annotating various clinical EEGs.

SAVES YOU TIME
Our solution reduces the time it takes to analyse an EEG by up to 80%.
RELEVANT

Developed in close collaboration with neurologists, we can ensure seamless integration into the clinical workflow as well as the quality and relevancy of the information presented to the diagnostician.

USER-FRIENDLY
An intuitive user interface allows for easy signal navigation and exploration, while significant cerebral events are automatically identified and presented for user review.
PRIVATE AND SECURE

Serious about patient privacy.

FLEXIBLE AND EASY-TO-ACCESS

As a cloud-based solution you have the flexibility to access the tool from any device or platform - all you need is an internet connection!

OPPORTUNITY: Automated Analysis

According to a recent study, 10 out of 10 neurologists find it useful to have quantitative analysis methods assist them in the everyday interpretation of routine EEGs. A significant portion of conclusions based on visual interpretation alone are subsequently altered because of quantitative analysis.

Scalability

Our solution scales quickly and easily to any number of customers, anywhere.

Patient Benefit

Our solution provides neurologists with an AI-based second opinion.

Integration

Our solution integrates seamlessly into existing clinical workflows.

OPPORTUNITY: Source Imaging

In research, source Imaging is the basis for many applications with proven benefits. But it is too time-consuming and too demanding to perform within the clinic. We offer a source imaging pipeline that is fast, reliable, and easy to use, such that it can be seamlessly integrated into routine clinical EEG analysis.

The first step in source imaging requires the recording of a routine low-density EEG.

To estimate the generators of the recorded EEG, it is combined with a head-MRI of the patient or, if not available, with an appropriate age-adjusted template. A wide selection of age-adjusted templates is part of our source imaging solution.

Source activity over time is visualized to give a qualitative overview of activation patterns. These time-dependent patterns build the basis for further analyses, e. g. estimations of functional or effective brain networks.

An example of such an analysis would be the estimation of effective connectivities, based on resting state EEG. Such networks can be used to measure disease progression, or predict cognitive decline, e. g. in Alzheimer's disease.

ABOUT US

Sebastian Mathias Keller
Co-founder & CEO
Cornelius Reyneke
Co-founder & CIO
Supported by

GET IN TOUCH...

for more information, send us a message.

Rekonas GmbH

We are located at Novartis Campus.

Lichtstr. 35
WSJ-500.1.101
4056 Basel

Press Coverage